FdaApplication
ANDA 206381
Identifiers
- fda_app_no: ANDA206381
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-04-24 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 10MG BASE | TABLET;ORAL |
| ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 5MG BASE | TABLET;ORAL |
| ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 20MG BASE | TABLET;ORAL |
| ROSUVASTATIN CALCIUM | ROSUVASTATIN CALCIUM | EQ 40MG BASE | TABLET;ORAL |
4 products